MedPath

Disordered Eating Risk in Pediatric Obesity Treatment Using a Digi-Physical Tool

Active, not recruiting
Conditions
Childhood Obesity
Disordered Eating
Binge Eating Disorder
Anorexia Nervosa
Bulimia Nervosa
Registration Number
NCT06807489
Lead Sponsor
Karolinska Institutet
Brief Summary

The goal of this observational study is to evaluate the risk of developing disordered eating behavior or an eating disorder among children and adolescents with obesity who have used a digi-physical treatment tool with daily measurements conducted at home.

The primary outcomes are to:

* Evaluate the proportion of patients exhibiting documented signs of disordered eating behaviors during or after treatment (e.g., caloric restriction, skipping meals, binge eating).

* Evaluate the proportion of patients diagnosed with an eating disorder (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder) during or after treatment.

Patients at Martina Childrens Hospital, Stockholm, Sweden, who have been treated with the digi-physical treatment tool will be included and their patient records will be reviewed for eating disorder diagnosis or a disturbed eating behavior.

Detailed Description

Children with chronic illnesses involving dietary restrictions as part of their treatment - such as obesity, diabetes mellitus, and celiac disease- are at an increased risk of developing eating disorders (ED) or disordered eating behaviors (DEB). Children with obesity are more likely to engage in unhealthy weight-control behaviors. Evidence-based, structured treatment programs for obesity do not elevate the risk of ED. On the contrary, such programs often intend to improve overall well-being. Professionally guided obesity treatment for children enhance self-esteem and has been shown to reduce both binge eating and loss of control over eating.

In this study, all participating children undergoing treatment for obesity will use a digi-physical treatment tool as a complement to behavioral treatment. This treatment tool includes daily measurements on a scale that does not show any digits, linked to a mobile app where weight development is shown as a moving average in the form of BMI standard deviation score (SDS). The app also provides an individualized target curve, visualizing the expected weight trajectory. Since weight changes in growing children are complex to interpret, BMI SDS is used as a standard metric. Objective data from the measuring device are automatically transferred to the database. Furthermore, direct communication between the clinic and the family is possible via the clinic interface and the app.

This study builds upon the investigators' previous one-year and three-year studies (ClinicalTrials.gov IDs: NCT04323215 and NCT06434259. The current follow-up study aims to evaluate the risk of developing DEB or an ED over a three-year period following the start of obesity treatment.

Approximately 400 children who have been treated with the digi-physical treatment tool will be included in the evaluation. Diagnoses and symptoms of DEB and ED will be retrieved from patient records.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Obesity according to International Obesity Task Force (IOTF)
  • Patients aged 6 years and older who have been treated with the digi-physical treatment tool
Exclusion Criteria
  • Patients with documented disordered eating behaviors or a diagnosed eating disorder prior to the start of treatment.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of Disordered Eating BehaviorsFrom start of treatment to three years follow-up

The proportion of patients exhibiting documented signs of disordered eating behaviors during or after treatment (e.g., caloric restriction, skipping meals, binge eating).

Referred patientsFrom start of treatment to three years follow-up

The proportion of patients referred to another clinic for further evaluation of a potential eating disorder.

Diagnosis of Eating DisorderFrom start of treatment to three years follow-up

The proportion of patients diagnosed with an eating disorder (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder).

Secondary Outcome Measures
NameTimeMethod
Time of Identification of Disordered Eating or Eating Disorder DiagnosisFrom start of treatment to three years follow-up

Identification of when, during the treatment process, signs of disordered eating or an eating disorder diagnosis are documented

Age of Onset of Eating DisorderFrom start of treatment to three years follow-up

The age at which the first documented signs of disordered eating behaviors or a diagnosed eating disorder occured.

Association with Neurodevelopmental DisordersFrom start of treatment to three years follow-up

Evaluation of the relationship between documented disordered eating behaviors or eating disorders and neurodevelopmental diagnoses, such as ADHD or autism.

Association with Mental Health IssuesFrom start of treatment to three years follow-up

Examination of how documented signs of disordered eating behaviors or eating disorders are related to other mental health issues, such as stress, anxiety, or depression.

Change in BMI SDS During TreatmentFrom start of treatment to the last measurement, up to three-years

Change in BMI SDS from the start of treatment as an indicator of treatment efficacy and its potential connection to disordered eating behaviors.

Measurement Frequency and AdherenceFrom start of treatment to three-years follow-up

Analysis of how frequently patients perform the recommended daily measurements and how this correlates with the risk of disordered eating behaviors or other treatment outcomes.

Association with Curve PatternsFrom start of treatment to the last measurement, up to three-years

Analysis of the growth or weight curve patterns to identify potential factors indicating disordered eating behaviors or eating disorders.

Trial Locations

Locations (1)

Childrens Hospital Martina

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath